Market Place
Sourcing Support
Roivant Reports Financial Results for the Q2 Ended September 30
12 Nov 2024 //
GLOBENEWSWIRE
Roivant to Report Q2 Results and Update on Nov 12, 2024
29 Oct 2024 //
GLOBENEWSWIRE
Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream
28 Oct 2024 //
#N/A
Organon pays up to $1.2B to acquire Dermavant and its steroid-free cream Vtama
19 Sep 2024 //
REUTERS
Roivant unveils new ‘vant’ to take forward Bayer’s inhaled hypertension med
11 Sep 2024 //
BIOSPACE
Roivant Unveils New Pipeline Program Mosliciguat
10 Sep 2024 //
GLOBENEWSWIRE
Pulmovant Presents Mosliciguat Phase 1b Data At ERS Congress
10 Sep 2024 //
GLOBENEWSWIRE
Roivant Provides Update on Graves’ Disease Development Program
09 Sep 2024 //
GLOBENEWSWIRE
Roivant Reports Q1 2025 Financial Results And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Roivant To Report Q1 2024 Results On August 8
25 Jul 2024 //
GLOBENEWSWIRE
Roivant Reports Fiscal Year 2024 Results And Business Update
30 May 2024 //
GLOBENEWSWIRE
Roivant To Report Q4, FY 2024 Results, Business Update May 30
16 May 2024 //
GLOBENEWSWIRE
Moderna shares fall after judge sides with Arbutus in patent fight
04 Apr 2024 //
REUTERS
Roivant`s anti-inflammatory drug shows promise in mid-stage study
03 Apr 2024 //
REUTERS
Roivant launches $1.5 billion share buyback program
02 Apr 2024 //
PRESS RELEASE
Roivant`s Hemavant bet winds down after cutting ex-Eisai drug
14 Feb 2024 //
FIERCE BIOTECH
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023
13 Feb 2024 //
GLOBENEWSWIRE
Roivant to Report Financial Results for the Q3 Ended December 31, 2023
30 Jan 2024 //
GLOBENEWSWIRE
Vivek Ramaswamy gives up presidential bid, no plans to return to Roivant
16 Jan 2024 //
ENDPTS
JPM24: Roivant CEO has ‘pangs of regret’ for letting Telavant go
12 Jan 2024 //
FIERCE BIOTECH
JPM24, Day 3: Gene editors talk BD; Roivant has cash to spend
10 Jan 2024 //
FIERCE BIOTECH
Roivant Reports Positive Phase 2 Results for Batoclimab in Graves™ Disease
20 Dec 2023 //
GLOBENEWSWIRE
Roche Completes Acquisition of Telavant from Roivant
14 Dec 2023 //
GLOBENEWSWIRE
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results
28 Nov 2023 //
GLOBENEWSWIRE
Roivant Sciences` lupus drug fails to reduce symptoms in mid-stage study
28 Nov 2023 //
REUTERS
Roivant Reports Financial Results for the Second Quarter Ended September 30
13 Nov 2023 //
GLOBENEWSWIRE
Roivant Announces Appointment of Mayukh Sukhatme to Its Board of Directors
10 Nov 2023 //
GLOBENEWSWIRE
Roivant to Report Financial Results for Second Quarter Ended September 30, 2023
30 Oct 2023 //
GLOBENEWSWIRE
Roche buys Roivant`s bowel disease drug for $7.1 billion
23 Oct 2023 //
REUTERS
Roivant FcRn inhibitor avoids cholesterol problem, shares spike
27 Sep 2023 //
FIERCE BIOTECH
Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD
26 Sep 2023 //
GLOBENEWSWIRE
Roivant Announces Completion of Redemption of its Outstanding Warrants
11 Sep 2023 //
GLOBENEWSWIRE
Roivant Announces Redemption Fair Market Value with Redemption of Warrants
17 Aug 2023 //
GLOBENEWSWIRE
Roivant Reports Financial Results for the First Quarter Ended June 30, 2023
14 Aug 2023 //
GLOBENEWSWIRE
Roivant CEO hints at more deals shaping up as key Immunovant data loom
14 Aug 2023 //
ENDPTS
Roivant to Report Financial Results for the Quarter Ended June 30, 2023
03 Aug 2023 //
GLOBENEWSWIRE
Roivant Announces Redemption of Outstanding Warrants
02 Aug 2023 //
GLOBENEWSWIRE
Roivant in talks to sell bowel disease drug to Roche in over $7 bln deal
14 Jul 2023 //
REUTERS
Roivant Reports Financial Results for the 4Q and Fiscal Year Ended March 31
28 Jun 2023 //
GLOBENEWSWIRE
Roivant to Report Financial Results for Q4 and Fiscal Year Ended March 31
26 Jun 2023 //
GLOBENEWSWIRE
Roivant to Host Investor Call at 8:00 AM ET Thursday, June 22 to Review Results
21 Jun 2023 //
GLOBENEWSWIRE
Roivant Reports Positive Topline Results from ADORING 1, Ph 3 Trial
16 May 2023 //
GLOBENEWSWIRE
Lokavant Emerges from Roivant Sciences with Multiple Industry Partnerships
04 Apr 2023 //
BUSINESSWIRE
Roivant Reports Positive Results from ADORING 2 Atopic Dermatitis PIII of VTAMA
15 Mar 2023 //
GLOBENEWSWIRE
Proteovant to Present Data from Estrogen Receptor and IKZF2 Protein Degrader
14 Mar 2023 //
GLOBENEWSWIRE
Roivant to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis
14 Mar 2023 //
GLOBENEWSWIRE
Covant Therapeutics Announces the Formation of its Scientific Advisory Board
07 Mar 2023 //
GLOBENEWSWIRE
Roivant founder Ramaswamy unveils `anti-woke` presidential bid
22 Feb 2023 //
FIERCE BIOTECH
Roivant Sciences Announces Change to its Board of Directors
21 Feb 2023 //
GLOBENEWSWIRE
Roivant Reports Financial Results for Q3 Ended December 31, 2022
13 Feb 2023 //
GLOBENEWSWIRE
Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
02 Feb 2023 //
GLOBENEWSWIRE
Roivant, Vera seek $100M+ raises as they look to fund drug hopefuls
02 Feb 2023 //
ENDPTS
Roivant Sciences Announces Proposed Public Offering of Common Shares
01 Feb 2023 //
GLOBENEWSWIRE
Roivant to Report Financial Results for Third Quarter Ended December 31, 2022
30 Jan 2023 //
GLOBENEWSWIRE
Roivant CEO: New data could make `23 `single most exciting year`
10 Jan 2023 //
FIERCEBIOTECH
Roivant Announces Meaningful Results from the Induction Period of TUSCANY-2
04 Jan 2023 //
GLOBENEWSWIRE
Phase 2 bowel disease data fire Prometheus` stock up 170%
08 Dec 2022 //
FIERCEBIOTECH
Roivant, Pfizer form new Vant company focused on developing TL1A drug candidat
03 Dec 2022 //
PHARMABIZ
Pfizer, Roivant set up new company around inflammation drug
02 Dec 2022 //
BIOPHARMADIVE
